Liposome and Their Applications in Cancer Therapy
Липосомы и их применение в терапии рака
2016-01-01
SCID: 54.1/qe2fk7ut
Discuss with AI
cancer therapydrug encapsulationliposomesnanocarriersphospholipid bilayers
Figures from the paper
Abstract (AI)
Liposomes, the vesicles of phospholipid bilayer, can encapsulate both hydrophilic and lipophilic drugs and protect them from degradation. Liposomes have been extensively studied and continue to create intense interest in research since their discovery in the mid-1960s. Since then, liposomes have been considered to be the most successful nanocarriers for drug deliver and have made their way to the market. Currently, a number of liposomal formulations are on the marker for cancer treatment and many more are in pipe line. This review discusses about the liposome components, methods of preparation, drug encapsulation mechanism and the potential therapeutic applications of liposomes in cancer therapy.
Key Findings
1
Encapsulation in liposomes protects drugs from degradation, supporting their use as drug-delivery carriers.
2
Liposomes are phospholipid-bilayer vesicles capable of encapsulating both hydrophilic and lipophilic drugs.
3
Liposomes have become among the most successful nanocarriers and have progressed from research into marketed products.
4
Several liposomal formulations are commercially available for cancer treatment, while additional formulations remain in development.
5
The review covers liposome components, preparation methods, drug-encapsulation mechanisms, and therapeutic applications in cancer therapy.
Research Object
liposomes used for cancer drug delivery
Research Subject
liposome composition, preparation methods, drug encapsulation mechanisms, and therapeutic applications in cancer therapy
Publication Details
Publication Date
2016-01-01
Journal
Publisher
ISSN
Cited by
130
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest